Mazaheri Mostafa, Tadayon Farhad, Khanbabapour Saeid, Omidi Ashkan, Salehi Hanieh, Kazemi Reza
Department of Urology, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.
Assistant Professor, Department of Urology, School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran.
Am J Clin Exp Urol. 2021 Jun 15;9(3):242-247. eCollection 2021.
Benign prostatic hyperplasia (BPH) is the most common benign mass in men, there are not standard parameter for diagnosis of BPH based on ultrasound bladder parameter, so the aim of the study was correlation between ultrasound bladder parameters with severity of symptoms and response to treatment in patients with benign prostatic hyperplasia under medical treatment.
This prospective cross-sectional study was performed on 100 men over 40 years of age with a diagnosis of BPH referred to the urology clinics of Al-Zahra and Khorshid hospitals, Isfahan, Iran in 2018-2020. The International Prostate Symptom Score (IPSS), bladder wall thickness, bladder weight, Intravesical prostatic protrusion (IPP) and response to treatment were examined before and after treatment. Patients underwent standard drug treatment with a Tamsulosin 0.4 mg daily and finasteride 5 mg daily for BPH and followed for a period of 3-6 months.
There were significant differences between severity of symptoms before treatment with age, bladder was thickness, bladder weight and IPP (P<0.001). The symptoms of 76 patients were recovered and 24 patients not changed After treatment, so the patients were compared based on outcomes to treat, all patients with mild symptoms, 28 patients with moderate symptoms and 18 patients with severe symptoms were recovered, so the treatment outcome was significant based on symptoms (P<0.001). The means of age, bladder wall thickness and bladder weight in recovered group was significantly lower than not changed group (P<0.001). Also the frequency of IPP in the recovered group was significantly lower than not changed group (P<0.001).
The use of ultrasound parameters has a high value in determining the response to treatment in BPH patients and the diagnostic value of IPSS, IPP, bladder wall thickness and bladder weight were important determined response to treatment and severity of disease. Also relation between bladder weight with response to treatment and severity of disease were evaluated for first time in the current study.
良性前列腺增生(BPH)是男性最常见的良性肿块,基于超声膀胱参数诊断BPH尚无标准参数,因此本研究的目的是探讨接受药物治疗的良性前列腺增生患者超声膀胱参数与症状严重程度及治疗反应之间的相关性。
本前瞻性横断面研究于2018 - 2020年对100名年龄超过40岁、诊断为BPH并转诊至伊朗伊斯法罕的阿尔扎赫拉医院和霍尔希德医院泌尿外科门诊的男性进行。在治疗前后检查国际前列腺症状评分(IPSS)、膀胱壁厚度、膀胱重量、膀胱内前列腺突出(IPP)及治疗反应。患者接受坦索罗辛0.4mg每日一次和非那雄胺5mg每日一次的标准药物治疗BPH,并随访3 - 6个月。
治疗前症状严重程度与年龄、膀胱壁厚度、膀胱重量和IPP之间存在显著差异(P<0.001)。治疗后76例患者症状好转,24例患者症状未改变,因此根据治疗结果对患者进行比较,所有轻度症状患者、28例中度症状患者和18例重度症状患者症状均好转,所以基于症状的治疗结果具有显著性(P<0.001)。好转组的年龄、膀胱壁厚度和膀胱重量均值显著低于未改变组(P<0.001)。此外,好转组的IPP频率显著低于未改变组(P<0.001)。
超声参数在确定BPH患者的治疗反应方面具有很高的价值,IPSS、IPP、膀胱壁厚度和膀胱重量的诊断价值对于确定治疗反应和疾病严重程度很重要。本研究首次评估了膀胱重量与治疗反应及疾病严重程度之间的关系。